PERK inhibition mitigates restenosis and thrombosis - a potential low-thrombogenic anti-restenotic paradigm
B. Wang, M. Zhang, G. Urabe, G. Chen, D. Wheeler, D. Dornbos, A. Huttinger, Y. Huang, S. Nimjee, S. Gong, L. Guo, K. C. Kent
This study shows that PERK inhibition reduces restenosis and thrombosis in animal models, suggesting it as a potential therapeutic strategy for drug-eluting stents.
bioRxiv · Mar 18, 2019 · PreprintPathology